TFLL Pharma

Life Sciences Incubator Belgium B. Abis B. Abis /

3590 Diepenbeek

BE

TFLL Pharma

Foundation date

16/09/2016

Sector

#Pharma

Subsector

Therapeutic areas

TFLL Pharma is a Contract Development Company which develops conventional finished dosage forms and special biotechnological products such as peptides for Pharmaceutical Companies. Expertise Small Molecules Solid dosage forms (Oral) Semi solid dosage and liquid forms (Topical) Parenteral dosage forms (Lyophilized, Liquid and PFS) Liquid dosage forms (Oral suspension and Solution)

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    19 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023